Robot model
Ion Endoluminal System
Intuitive Surgical's Ion Endoluminal System is a robotic-assisted bronchoscopy platform for minimally invasive biopsy of peripheral lung nodules.
- Manufacturer
- Intuitive Surgical
- Form factor
- surgical
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 1
Overview
Intuitive Surgical's Ion Endoluminal System is a robotic-assisted bronchoscopy platform for minimally invasive biopsy of peripheral lung nodules. It uses an ultra-thin, shape-sensing maneuverable catheter with PlanPoint CT-based airway planning to reach lesions deep in the peripheral lung. FDA 510(k) cleared in February 2019 and commercially deployed across US hospitals, with subsequent AI and advanced-imaging integration clearances.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Verified deployments
- 1 deployment on file
- Sources on file
- 2 sources, view all
Key facts
FDA clearance
Specs
Pathway
Modality
Planning
Indication
Data & sources
Press releases
1
Web sources
1
2 sources backing this record.View all →
Pricing
No verified price is on record for Ion Endoluminal System. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Deployments (1)
- Ion Endoluminal System at United Statesoperational
Ion Endoluminal System (Intuitive Surgical) operating in United States.
Ion Endoluminal System on the deployment map
Where Ion Endoluminal System is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 5, 2026
Added to the verified registry
- Verified media addedVerifiedJun 5, 2026
Introducing Ion by Intuitive
- Price point recordedJan 1, 2024
Not announced
- Deployment verifiedVerifiedJun 1, 2019
at United States
Deployment-verified media (1)
Intuitive Surgical's introduction of Ion, its robotic-assisted bronchoscopy platform for minimally invasive peripheral-lung biopsy. Physician-driven via a shape-sensing catheter; not autonomous.
From deployment: United States
Regulatory filings (5)
- Z-1134-2026fda recall · us_fdarecalled2025-12-04
Applicant: Intuitive Surgical
- Z-2720-2024fda recall · us_fdarecalled2024-07-12
Applicant: Intuitive Surgical
- Z-0106-2022fda recall · us_fdarecalled2021-08-06
Applicant: Intuitive Surgical
- Z-0489-2021fda recall · us_fdarecalled2020-10-23
Applicant: Intuitive Surgical
- K182188fda 510k · us_fdacleared2018-08-13
Applicant: Intuitive Surgical
Safety record
No incidents on record for Ion Endoluminal System.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (2)
Common questions
- What is Ion Endoluminal System?
- Intuitive Surgical's Ion Endoluminal System is a robotic-assisted bronchoscopy platform for minimally invasive biopsy of peripheral lung nodules. It uses an ultra-thin, shape-sensing maneuverable catheter with PlanPoint CT-based airway planning to reach lesions deep in the peripheral lung. FDA 510(k) cleared in February 2019 and commercially deployed across US hospitals, with subsequent AI and advanced-imaging integration clearances.
- How much does Ion Endoluminal System cost?
- Ion Endoluminal System's price is not publicly disclosed. DEPLOY has no verified price on record for Ion Endoluminal System from Intuitive Surgical. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
- Is Ion Endoluminal System actually deployed in the real world?
- Yes. Ion Endoluminal System is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
- Who makes Ion Endoluminal System?
- Ion Endoluminal System is made by Intuitive Surgical, based in Sunnyvale, California, USA, founded in 1995.
- Where is Ion Endoluminal System deployed?
- 1 verified deployment of Ion Endoluminal System is on the DEPLOY registry, including at United States.
- Can you buy Ion Endoluminal System?
- Ion Endoluminal System is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
- Is Ion Endoluminal System FDA cleared?
- Ion Endoluminal System has 5 regulatory records on the DEPLOY registry: FDA recall (Z-1134-2026), recalled; FDA recall (Z-2720-2024), recalled; FDA recall (Z-0106-2022), recalled and 2 more. See the Regulatory filings section for each agency source.
- What are alternatives to Ion Endoluminal System?
- On the DEPLOY registry, comparable surgical robots to Ion Endoluminal System include Toumai, da Vinci (and Ion), Epione, Hugo RAS.
- How does Ion Endoluminal System compare to Toumai?
- Ion Endoluminal System and Toumai (MicroPort MedBot · 8 deployments) are both surgical robots on the DEPLOY registry. Ion Endoluminal System has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
- Is Ion Endoluminal System a top surgical?
- On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Ion Endoluminal System ranks in roughly the top 21% of surgical models tracked by the registry.
- What is Ion Endoluminal System's maturity stage?
- Ion Endoluminal System is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
- Is Ion Endoluminal System safe?
- Ion Endoluminal System has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-07-14
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-07-14
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- primary-company-ir
- Company IR disclosure
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Ion Endoluminal System.Recent coverage
Ion Endoluminal System in third-party press
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning Ion Endoluminal System from third-party publications. Automatically surfaced; not part of the verified registry record.
Intuitive Surgical Stock Is Up Over 400%. Here's Why It's Still a No-Brainer Buy. - The Motley Fool
<a…
Intuitive Surgical Stock Is Up Over 400%. Here's Why It's Still a No-Brainer Buy. - Yahoo Finance
<a…
Alva Industries raises EUR 16M for electric motor technology
Alva Industries raised EUR 16M to scale breakthrough electric motor technology for surgical robotics.
Goldman Sachs Intuitive Surgical call goes against the grain - thestreet.com
<a…
Surgical robots to heavy-duty trucks: UNOPS procurement delivers impact globally
UNOPS procured .4B worth of equipment in 2025 including surgical robots and heavy-duty trucks. Global procurement impact.
FDA Class 2 Device Recall: Da Vinci X and Xi manipulator screws
FDA Class 2 recall for da Vinci X and Xi. Intuitive Surgical recall due to manipulator containing screws within arm sub-assembly.
FDA authorizes more devices in 2026 but it's taking longer
FDA authorized more AI-enabled devices in first half of 2026 but average time to clearance increased by 7-8 days. Average ~156 days to decision.
FDA AI-Enabled Medical Devices List - Updated 2026
FDA's AI-Enabled Medical Device List identifying AI-enabled devices authorized for marketing in the US. Record 295 clearances in 2025.
5 robotic surgery trends to watch in 2026
MedTech Dive: Soft tissue robotic systems expanding into new specialties. Medtronic Hugo competition with Intuitive. Distalmotion Dexter gaining traction. ASC adoption growing.
Intuitive Secures FDA Clearance for Expanded da Vinci SP Uses
Intuitive Surgical received FDA clearance for expanded uses of the da Vinci SP single-port robotic surgical system, despite being downgraded by analysts.
Portneuf Medical Center lets public try surgical robot
Portneuf Medical Center invited community to hands-on look at robotic surgery during 'Meet the Robot' event.
Kootenai Health debuts new surgical robot - Spokane Journal of Business
<a…
Machine-readable surfaces
- Markdown mirror: /models/intuitive-ion.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/0e2f5d6f-8ce6-4726-9301-d438ecf732bc
- Revision history: /models/intuitive-ion/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Video
The da Vinci® robotic surgical system is an innovative, minimally invasive procedure. Learn more about the da Vinci robotic surgical system by watching it in ac
The da Vinci SP enables surgeons to deliver robotic surgery through a single port or incision. Watch a demo of its unique and innovative features in action. Su
Da Vinci Xi Surgical System by Intuitive PN 1004941 US REV D 11/2015
Take a tour of Intuitive’s manufacturing facility to see inside the robot. Find out how people and processes come together to make da Vinci surgical systems.
Reality vs attention
Ion Endoluminal System draws attention at the 99th percentile but verifies reality at the 23rd percentile among surgical robots. Hype Gap +76.1, 1st widest among surgical robots.
6-month trend
Analysis
Strong recent media coverage and press activity. Thin deployment record; scale validation still in progress.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 23, 2026